Patient Site

The contents provided by this page is intended for patients prescribed with Remsima®. If you are an Australian Healthcare Professional , please click the button to the right.

HEALTHCARE
PROFESSIONALS COMPANY
INFORMATION
About us About Remsima® How Remsima® works

About Remsima®

What is Remsima® ? About Remsima®

This site is only for residents of Australia who have been prescribed Remsima®.

Please enter the six digit number shown on your Remsima carton
following the letters 'AUSTR'


Leave Enter

Remsima® contains the active ingredient infliximab and is injected subcutaneously (under the skin).

Remsima® comes in a pre-filled pen and pre-filled syringe with needle guard.1,2

Subcutaneous Injection

  • Remsima® 120 mg solution for subcutaneous injection in pre-filled pen

  • Remsima® 120 mg solution for subcutaneous injection in
    pre-filled syringe with needle guard

    • Reference

    1. Remsima® Australian Consumer Medicine Information (CMI) PF pen. Available at: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01619-1 Accessed January 2023.

    2. Remsima® Australian Consumer Medicine Information (CMI) PF syringe. Available at: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01618-1 Accessed January 2023.

    Consumer Medicine Information (CMI) PF Pen and PF Syringe Leaflet Privacy Policy Terms of Use Company

    Celltrion Healthcare Australia Pty Ltd. Suite 13.03, 31 Market Street, Sydney, NSW 2000.

    T: 1800 325 228   E: info-anz@celltrionhc.com

    This website last updated October 2023.